drospirenone has been researched along with Bone Loss, Perimenopausal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, S; Choi, YS; Jeon, YE; Lee, BS; Lim, KJ; Seo, SK; Yang, HI | 1 |
| Christiansen, C; Nielsen, T; Ravn, P; Warming, L | 1 |
| Bakris, G; Hanes, V; Norris, PM; Pitt, B; Preston, RA; White, WB | 1 |
| Skouby, SO | 1 |
1 review(s) available for drospirenone and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
The rationale for a wider range of progestogens.
Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome | 2000 |
3 trial(s) available for drospirenone and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Changes in serum levels of cartilage oligomeric matrix protein after estrogen and alendronate therapy in postmenopausal women.
Topics: Aged; Alendronate; Androstenes; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cartilage; Cartilage Oligomeric Matrix Protein; Estradiol; Extracellular Matrix Proteins; Female; Glycoproteins; Humans; Matrilin Proteins; Middle Aged; Mineralocorticoid Receptor Antagonists; Osteoarthritis; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause | 2012 |
Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.
Topics: Aged; Alkaline Phosphatase; Androstenes; Biomarkers; Bone Density; Bone Remodeling; Cholesterol; Collagen; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Progesterone Congeners; Prospective Studies; Ultrasonography | 2004 |
Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
Topics: Administration, Oral; Adult; Aged; Androstenes; Blood Pressure; Drug Therapy, Combination; Estradiol; Female; Follow-Up Studies; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Osteoporosis, Postmenopausal; Potassium; Safety; Treatment Outcome | 2005 |